Faculty Profile, National Health Research Institutes, Taiwan

Faculty Profiles


Yung-Ching Liu, M.D.

Joint-appointed Associate Investigator
Division of Infectious Diseases
ycliu@isca.vghks.gov.tw

EDUCATION

M.D., College of Medicine, National Taiwan University, Taiwan

PROFESSIONAL EXPERIENCES

- Joint-appointed Associate Investigator, Division of Clinical Research, National Health Research Institutes, Taiwan (2005-present)
- Chief of Microbiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan (2005- present)
- Attending physician of Infectious Diseases, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan (2005- present)
- Chief of Infectious Diseases and Microbiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan (1990- 2005)
- Attending physician of Infectious Diseases, Taipei Veterans (1986- 1989)
- Fellowship in Sloan-Kettering Memorial Hospital, New York, USA (trained in Clinical Virology) (1987- 1988)
- Chief Resident of Infectious Diseases, Taipei Veterans General (1984-1985)
- Resident in Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.(1978- 1983)

RESEARCH INTERESTS

Dr. Liu's early research interest was in virology and HIV/AIDS, then evolved into research in the area of rational use of antibiotics and laboratory diagnosis of mycobacteria. His recent research interest is in latent tuberculosis infection and the use of whole blood interferon gamma assay in the diagnosis of tuberculosis infection.

RESEARCH ACTIVITIES & ACCOMPLISHMENTS

Dr. Liu's research activity and accomplishments focus on the following two areas:
1. Studies to improve laboratory diagnosis of Mycobacterial tuberculosis
2. Studies addressing the rational use and abuse of antibiotics in Taiwan.
His numerous original publications demonstrated his accomplishments.

SELECTED PUBLICATIONS

1. Huang TS, Lee SS, Tu HZ, Huang WK, Chen YS, Huang CK, Wann SR, Lin HH, Liu YC. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide. J Antimicrob Chemother. 53(4):600-3, 2004.
2. Huang TS, Huang WK, Lee SS, Tu HZ, Chang SH, Liu YC. Rapid detection of pulmonary tuberculosis using the BDProbeTEC ET Mycobacterium tuberculosis Complex Direct Detection Assay (DTB). Diagn Microbiol Infect Dis. 46(1):29-33, 2003.
3. Huang TS, Tu HZ, Lee SS, Huang WK, Liu YC. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems. Ann Clin Lab Sci. 32(2):142-7, 2002.
4. Huang TS, Chen CS, Lee SS, Huang WK, Liu YC. Comparison of the BACTEC MGIT 960 and BACTEC 460TB systems for detection of mycobacteria in clinical specimens. Ann Clin Lab Sci.31(3):279-83, 2001.
5. Liu YC, Huang WK, Huang TS, Kunin CM. Inappropriate use of antibiotics and the risk for delayed admission and masked diagnosis of infectious diseases: a lesson from Taiwan. Arch Intern Med.161(19):2366-70, 2001.
6. Liu YC, Huang WK, Huang TS, Kunin CM. Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine.Lancet. 354(9187):1360, 1999.
7. Liu YC, Huang WK, Huang TS, Kunin CM. Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use. J Clin Epidemiol. 52(6):539-45, 1999.